These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 870274)

  • 1. Aminopyrine metabolism in the presence of hyperbilirubinemia due to cholestasis or hepatocellular disease. Combined use of laboratory tests to study disease-induced alterations in drug disposition.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1977 May; 21(5):620-6. PubMed ID: 870274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine.
    Hepner GW; Vesell ES
    Ann Intern Med; 1975 Nov; 83(5):632-8. PubMed ID: 1200495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath test.
    Hepner GW; Uhlin SR; Lipton A; Harvey HA; Rohrer V
    JAMA; 1976 Oct; 236(14):1587-90. PubMed ID: 989131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseases.
    Pauwels S; Geubel AP; Dive C; Beckers C
    Dig Dis Sci; 1982 Jan; 27(1):49-56. PubMed ID: 6802621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.
    Morelli A; Narducci F; Pelli MA; Farroni F; Vedovelli A
    Am J Gastroenterol; 1981 Aug; 76(2):110-3. PubMed ID: 6795921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.
    Haustein KO; Schenker E
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):190-6. PubMed ID: 3922902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminopyrine demethylation measured by breath analysis in cirrhosis.
    Bircher J; Küpfer A; Gikalov I; Preisig R
    Clin Pharmacol Ther; 1976 Oct; 20(4):484-92. PubMed ID: 975720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH
    Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis.
    Baker AL; Krager PS; Kotake AN; Schoeller DA
    Hepatology; 1987; 7(3):464-7. PubMed ID: 3570158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited usefulness of the breath test in evaluation of drug metabolism: a study in human oral contraceptive users treated with dimethylaminoantipyrine and diazepam.
    Sonnenberg A; Koelz HR; Herz R; Benes I; Blum AL
    Hepatogastroenterology; 1980 Apr; 27(2):104-8. PubMed ID: 6783497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The [14C]-aminopyrine breath test. A comparison of different forms of analysis.
    Henry DA; Sharpe G; Chaplain S; Cartwright S; Kitchingman G; Bell GD; Langman MJ
    Br J Clin Pharmacol; 1979 Dec; 8(6):539-45. PubMed ID: 533576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of liver function by the aminopyrine breath test.
    Villeneuve JP; Arsène D; Huet PM
    Clin Invest Med; 1983; 6(1):5-9. PubMed ID: 6403268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperbilirubinemia and cholestasis.
    Berk PD; Javitt NB
    Am J Med; 1978 Feb; 64(2):311-26. PubMed ID: 415609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis.
    Hepner GW; Vesell ES
    N Engl J Med; 1974 Dec; 291(26):1384-8. PubMed ID: 4427643
    [No Abstract]   [Full Text] [Related]  

  • 16. Output of 14CO2 in breath after oral administration of (14C-methyl) aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: its relationship to aminopyrine pharmacokinetics.
    Noordhoek J; Dees J; Savenije-Chapel EM; Wilson JH
    Eur J Clin Pharmacol; 1978 May; 13(3):223-9. PubMed ID: 668778
    [No Abstract]   [Full Text] [Related]  

  • 17. The aminopyrine breath test as a measure of liver function. A quantitative description of its metabolic basis in normal subjects.
    Irving CS; Schoeller DA; Nakamura KI; Baker AL; Klein PD
    J Lab Clin Med; 1982 Sep; 100(3):356-73. PubMed ID: 6809872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental hepatobiliary injury. Comparison of in vivo drug elimination with in vitro drug-metabolizing enzyme capacity in the rat.
    Willson RA; Hart FE; Hew JT
    Dig Dis Sci; 1981 Jan; 26(1):50-9. PubMed ID: 6780282
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of hepatic tetrahydrofolate and inhibition of exhalation of 14CO2 formed from [dimethylamino-14C]aminopyrine in nitrous oxide-treated rats.
    Black KA; Virayotha V; Tephly TR
    Hepatology; 1984; 4(5):871-6. PubMed ID: 6434391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
    Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
    Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.